Hikma Ventures is the corporate venture capital arm of Hikma Pharmaceuticals. It invests in innovative healthcare companies, particularly businesses developing medicines, healthcare technologies, and services relevant to Hikma’s pharmaceutical markets.
Subscribe to see Hikma Ventures’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Hikma Ventures is a company headquartered in United Kingdom. Xcout tracks 8 named people at Hikma Ventures, including Lana Ghanem (Managing Director).
2 more named people on record for Hikma Ventures, with roles, board committees and tenure — see the full roster →
A few of Hikma Ventures's closest competitors — see the full list of competitors and alternatives →
CVS Health Ventures is the corporate venture capital arm of CVS Health. It invests in healthcare technology and services companies, including businesses focused on digital health, care delivery, and consumer health, to support innovation relevant to CVS Health and its customers.
McKesson Ventures is the corporate venture capital arm of McKesson Corporation. It invests in healthcare technology and services companies, particularly those serving providers, payers, pharmacies, and patients, and supports innovations relevant to the healthcare supply chain and delivery system.
Eli Lilly Ventures is the corporate venture-capital arm of Eli Lilly and Company, investing in early-stage biotechnology and healthcare companies. It supports entrepreneurs developing therapeutics, medical technologies, and related healthcare innovations.
Cedars-Sinai Health Ventures is the corporate venture investment arm of Cedars-Sinai, supporting and investing in healthcare companies developing technologies, therapies, and services. It works with healthcare entrepreneurs and startups while seeking innovations relevant to patients, clinicians, and the broader healthcare system.
Hikma Pharmaceuticals PLC is a global pharmaceutical enterprise involved in the creation, production, promotion, and distribution of a wide array of generic, branded, and licensed medicinal solutions. These offerings are presented in various dosage formats, including solid, semi-solid, liquid, and injectable forms. The company's operations are strategically structured into three core segments: Injectables, Generics, and Branded. The Injectables division specializes in providing generic injectable medications, predominantly for hospital environments. Conversely, the Generics segment is responsible for supplying oral and other non-injectable generic pharmaceuticals to the consumer retail market. The Branded unit caters to both retail and hospital clients with its proprietary generic and in-licensed products. Hikma's comprehensive product portfolio addresses a broad spectrum of medical conditions, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, and respiratory ailments. The firm boasts a substantial international presence, conducting business across the United Kingdom, the United States, the Middle East, North Africa, and various European countries. Founded in 1978, the company's corporate headquarters are situated in London, United Kingdom.
Philips Ventures is the corporate venture investment arm of Royal Philips, investing in companies developing healthcare technologies and solutions. It focuses on startups and growth-stage businesses that align with Philips’ health-tech strategy and can contribute to improving healthcare delivery.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Hikma Ventures? Suggest a correction
Post the link and the card appears automatically — each network fetches the image itself.